| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension
|
Riccioni, Graziano
|
|
2009
|
26 |
7 |
p. 700-710
|
artikel
|
| 2 |
Comparing hydrocortisone and methylprednisolone in patients with septic shock
|
Yu, Teng-Jen
|
|
2009
|
26 |
7 |
p. 728-735
|
artikel
|
| 3 |
Dyslipidemia therapy update: the importance of full lipid profile assessment
|
Menown, I. B. A.
|
|
2009
|
26 |
7 |
p. 711-718
|
artikel
|
| 4 |
Erratum to: Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
|
Simpson, Kit N.
|
|
2009
|
26 |
7 |
p. 737
|
artikel
|
| 5 |
Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
|
Tahrani, Abd A.
|
|
2009
|
26 |
7 |
p. 736
|
artikel
|
| 6 |
Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases
|
Beeh, Kai M.
|
|
2009
|
26 |
7 |
p. 691-699
|
artikel
|
| 7 |
Omacor® (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia
|
Rupp, Heinz
|
|
2009
|
26 |
7 |
p. 675-690
|
artikel
|
| 8 |
Therapeutic effect of 1,5-pentanediol for herpes simplex labialis: a randomized, double-blind, placebo-controlled clinical trial
|
Busch, Regina
|
|
2009
|
26 |
7 |
p. 719-727
|
artikel
|
Tijdschrift beschrijving